[1] Folkman J.Tumor angiogenesis:therapeutic implications[J].N En glJ Med,1971,285(21):1182-1186.
[2] 李晓光,李宁毅,刘太生,等.VEGF表达在口腔癌中的意义[J].上海口腔医学,2003,12(2):123-126.
[3] Hannigan G,Troussard AA,Dedhar S.Integrin-linked kinase:a cancer therapeutic target unique among its ILK[J].Nat Rev Cancer,2005,5(1):51-63.
[4] Lan RF, Liu ZX, Song YE, et al.Effects of CD151 on migration of human tongue squamous carcinoma cell line Tca8113[J].Ai Zheng,2005,24(3):262-267.
[5] Senger DR,Galli SJ,Dvorak AM,et al.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J].Science,1983,219(4587):983-985.
[6] Gasparini G,Toi M,Biganzoli E,et al.Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors,p53,cathepsin D,hormone receptors and prognosis[J]. Oncology
2001,60(1):72-80.
[7] Bian XW,Du LL,Shi JQ,et al.Correlation of bFGF,FGFR and VEGF expression with vascularity and malignancy of human astrocytomas[J].Analyt Quant Cytol Histol,2000,22(3):267-274.
[8] Fan TP.Angiosuppressive therapy for cancer[J].Trends Pharmacol Sci,1994,15(2):33-36.
[9] 徐伟. 血管内皮生长因子在消化系统肿瘤中的研究进展[J].医学研究生学报,2009,22(10):1084-1087.
[10] 李永利,杨立庄.血管内皮细胞特异性生长因子与胶质瘤血管生成[J].中华神经外科疾病研究杂志,2005,4(1):93-94.
[11] 饶娅敏,陈同钰.HIF-1α、COX-2、VEGF与胶质瘤[J].现代肿瘤医学,2006,16(2):145-147.
[12] 王俊,袁志诚,施洋.p53,Ki67,VEGF和MMP-9在胶质瘤中的表达及意义[J].江苏大学学报(医学版),2007,17(3):228-231.
[13] Hannigan GE,Leung-Hagesteijn C,Fitz-Gibbon L,et al.Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase[J].Nature,1996, 379(6560):91-96.
[14] 杜菲,黄常志.整合素相关激酶(ILK)研究进展[J].国外医学-分子生物学分册,2001,23(3):142-145.
[15] 王小强,张建生,霍龙伟,等.ILK与PKB在人脑胶质瘤组织中的表达及临床意义[J].中华神经外科疾病研究杂志,2010,9(1):19-22.
[16] Koul D,Shen R,Bergh S,et al.Targeting integrin linked-kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma[J].Mol Cancer Ther,2005,4(11):1681-1688.
[17] Ashman LK,Aylett GW,Mehrabani PA,et al.Berndt MC:The murine mono-clonal antibody,14A2.Hl, identifies a novel platelet surface antigen[J].Br J Haematol,1991,79(2):263-270.
[18] Ashman LK.CD151[J].J Biol Regul Homeost Agents,2002,16(3):223-226.
[19] Shi GM,Ke AW,Zhou J,et al.CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma[J].Hepatology,2010, 52(1):183-196.
[20] Chung J,Mercurio AM.Contributions of the alpha6 integris to breast carcinoma survival and progression[J].Mol Cells,2004,17(2):203-209.
[21] 王丽,杨军,刘正湘,等.CD151对大鼠心肌梗死后血管新生及心功能的影响[J].中华心血管杂志,2006,34(2):159-163.
[22] Rao Malla R,Gopinath S,Alapati K,et al.Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma[J].Mol Carcinog,2013,52(10): 777-790. |
